Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccines in Patients With Hypersensitivity to First Dose

Two mRNA coronavirus disease 2019 (COVID-19) vaccines, Moderna and Pfizer-BioNTech, require 2 doses for maximum efficacy. This case series reports the safety and immunogenicity of a graded administration of the second dose of the Moderna and Pfizer-BioNTech COVID-19 vaccines in patients with immedia...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuong, Linh-An C, Capucilli, Peter, Staicu, Mary, Ramsey, Allison, Walsh, Edward E, Shahzad Mustafa, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500168/
https://www.ncbi.nlm.nih.gov/pubmed/34873577
http://dx.doi.org/10.1093/ofid/ofab507
_version_ 1784580397922779136
author Tuong, Linh-An C
Capucilli, Peter
Staicu, Mary
Ramsey, Allison
Walsh, Edward E
Shahzad Mustafa, S
author_facet Tuong, Linh-An C
Capucilli, Peter
Staicu, Mary
Ramsey, Allison
Walsh, Edward E
Shahzad Mustafa, S
author_sort Tuong, Linh-An C
collection PubMed
description Two mRNA coronavirus disease 2019 (COVID-19) vaccines, Moderna and Pfizer-BioNTech, require 2 doses for maximum efficacy. This case series reports the safety and immunogenicity of a graded administration of the second dose of the Moderna and Pfizer-BioNTech COVID-19 vaccines in patients with immediate hypersensitivity reactions to the first dose.
format Online
Article
Text
id pubmed-8500168
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-85001682021-10-08 Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccines in Patients With Hypersensitivity to First Dose Tuong, Linh-An C Capucilli, Peter Staicu, Mary Ramsey, Allison Walsh, Edward E Shahzad Mustafa, S Open Forum Infect Dis Brief Reports Two mRNA coronavirus disease 2019 (COVID-19) vaccines, Moderna and Pfizer-BioNTech, require 2 doses for maximum efficacy. This case series reports the safety and immunogenicity of a graded administration of the second dose of the Moderna and Pfizer-BioNTech COVID-19 vaccines in patients with immediate hypersensitivity reactions to the first dose. Oxford University Press 2021-10-06 /pmc/articles/PMC8500168/ /pubmed/34873577 http://dx.doi.org/10.1093/ofid/ofab507 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Brief Reports
Tuong, Linh-An C
Capucilli, Peter
Staicu, Mary
Ramsey, Allison
Walsh, Edward E
Shahzad Mustafa, S
Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccines in Patients With Hypersensitivity to First Dose
title Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccines in Patients With Hypersensitivity to First Dose
title_full Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccines in Patients With Hypersensitivity to First Dose
title_fullStr Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccines in Patients With Hypersensitivity to First Dose
title_full_unstemmed Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccines in Patients With Hypersensitivity to First Dose
title_short Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccines in Patients With Hypersensitivity to First Dose
title_sort graded administration of second dose of moderna and pfizer-biontech covid-19 mrna vaccines in patients with hypersensitivity to first dose
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500168/
https://www.ncbi.nlm.nih.gov/pubmed/34873577
http://dx.doi.org/10.1093/ofid/ofab507
work_keys_str_mv AT tuonglinhanc gradedadministrationofseconddoseofmodernaandpfizerbiontechcovid19mrnavaccinesinpatientswithhypersensitivitytofirstdose
AT capucillipeter gradedadministrationofseconddoseofmodernaandpfizerbiontechcovid19mrnavaccinesinpatientswithhypersensitivitytofirstdose
AT staicumary gradedadministrationofseconddoseofmodernaandpfizerbiontechcovid19mrnavaccinesinpatientswithhypersensitivitytofirstdose
AT ramseyallison gradedadministrationofseconddoseofmodernaandpfizerbiontechcovid19mrnavaccinesinpatientswithhypersensitivitytofirstdose
AT walshedwarde gradedadministrationofseconddoseofmodernaandpfizerbiontechcovid19mrnavaccinesinpatientswithhypersensitivitytofirstdose
AT shahzadmustafas gradedadministrationofseconddoseofmodernaandpfizerbiontechcovid19mrnavaccinesinpatientswithhypersensitivitytofirstdose

Ejemplares similares